Your browser doesn't support javascript.
loading
Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain Metastases.
Mahashabde, Ruchira; Bhatti, Sajjad A; Martin, Bradley C; Painter, Jacob T; Rodriguez, Analiz; Ying, Jun; Li, Chenghui.
Afiliação
  • Mahashabde R; Division of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Bhatti SA; Department of Hematology and Medical Oncology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Martin BC; Division of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Painter JT; Division of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Rodriguez A; Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Ying J; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Li C; Division of Pharmaceutical Evaluation and Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR.
JCO Oncol Pract ; 19(11): 1009-1019, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37729600

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article